Elliot Wilbur

Stock Analyst at Raymond James

(1.50)
# 1,386
Out of 4,495 analysts
43
Total ratings
30.43%
Success rate
-5.27%
Average return

13 Stocks

ADMA Biologics
May 10, 2024
Maintains: Strong Buy
Price Target: $8$10
Current: $13.05
Upside: -23.37%
Sol-Gel Technologies
Aug 11, 2023
Maintains: Strong Buy
Price Target: $9$7
Current: $0.86
Upside: +710.37%
ANI Pharmaceuticals
May 9, 2023
Maintains: Outperform
Price Target: $48$49
Current: $61.35
Upside: -20.13%
Organon & Co.
Mar 16, 2023
Initiates: Outperform
Price Target: $33
Current: $20.97
Upside: +57.37%
Perrigo Company
Mar 6, 2023
Maintains: Outperform
Price Target: $42$43
Current: $27.65
Upside: +55.52%
PetIQ
Oct 25, 2022
Maintains: Outperform
Price Target: $21$16
Current: $21.72
Upside: -26.34%
PolyPid
Sep 6, 2022
Downgrades: Outperform
Price Target: $450$120
Current: $3.50
Upside: +3,328.57%
Viatris
Mar 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $11.77
Upside: -
Teva Pharmaceutical
Oct 28, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $16.34
Upside: -
Zoetis
Jul 16, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $179.23
Upside: -
Elanco Animal Health
Jan 10, 2020
Initiates: Market Perform
Price Target: n/a
Current: $12.87
Upside: -
Journey Medical
Jan 17, 2019
Upgrades: Market Perform
Price Target: n/a
Current: $5.51
Upside: -
Amphastar Pharmaceuticals
Nov 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $39.75
Upside: -